Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
  1. 4 Shares withheld for taxes Chief Financial Officer gave up 2,215 shares (to pay taxes)
  2. 4 Shares withheld for taxes President & COO gave up 2,238 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,266 shares (to pay taxes)
  4. 4 Planned sale CEO sold 1,000 shares at $15.00 ($15,000)
  5. 4 Planned sale CEO sold 1,000 shares at $15.99 ($15,990)
  6. 4 Planned sale Chief Financial Officer sold 12,500 shares at an average $15.59 ($194,845)
  7. 4 Planned sale President and CEO sold 1,000 shares at $15.00 ($15,000)
  8. 4 Planned sale President and CEO sold 1,000 shares at $16.23 ($16,230)
  9. 4 Planned sale President and CEO sold 1,000 shares at $15.00 ($15,000)
  10. 4 Planned sale President and CEO sold 1,000 shares at $15.00 ($15,000)
  11. 4 Shares withheld for taxes President and CEO gave up 1,440 shares (to pay taxes)
  12. 4 Planned sale Chief Financial Officer sold 950 shares at an average $13.48 ($12,806)
  13. 4 Shares withheld for taxes Chief Scientific Officer gave up 449 shares (to pay taxes)
  14. 4 Planned sale Chief Medical Officer sold 892 shares at an average $13.48 ($12,022)
  15. 4 Planned sale Chief Operating Officer sold 972 shares at an average $13.47 ($13,089)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Planned sale President and CEO sold 1,000 shares at $15.67 ($15,671)
  19. 4 Planned sale Chief Medical Officer sold 26,710 shares at an average $14.76 ($394,219)
  20. 4 Planned sale Chief Financial Officer sold 10,000 shares at an average $17.99 ($179,862)

Page 6 of 13 · 242 filings